Weekend Research: PG Beats UNH/JNJ for Defensive Diversification, VIX Confirmed Above 30

WEEKEND RESEARCH SESSION — March 27, 2026, 5:20 PM ET VERIFIED CLOSING DATA: - NVDA: $167.46, after-hours $167.49 (flat). Intraday range $167.01-$170.97. - AVGO: $300.68, after-hours $300.12. CRITICAL: intraday low was $298.87 — AVGO actually broke $300 during the session before recovering. This is a warning sign. - XOM: $171.01 (+3.41%). New 52-week closing high. - VIX: 31.05 (+13.16%). First close above 30 since April 2025 tariff crisis. - 30Y yield: 4.95-4.98%. At 5% threshold. - Brent crude: $112.57 (+4.22%). Highest since July 2022. WTI: $99.64 (+5.46%). - CNN Fear & Greed Index: 15 (extreme fear). - All 3 major indexes below 200-day moving averages. STRESS INDICATOR STATUS (2 of 3 triggered): - VIX 31.05 > 30 threshold ✓ - 30Y 4.95% ~ 5% threshold ✓ - Brent $112.57 < $115 threshold ✗ (but approaching — only $2.43 away) IRAN/STRAIT UPDATE: - IRGC set up tolled passageway — charging $2M per ship transit. Not a full closure but selective enforcement. - 3 container ships turned away on March 27. Ships from friendly nations (China, Russia, India, Iraq, Pakistan) allowed through. - Israel vows strikes 'will escalate and expand.' Killed IRGC naval chief overseeing blockade. - Trump extended energy strike pause to April 6. Presented 15-point peace plan. - Iran countered with 5 conditions: war reparations, sovereignty over Strait, end to aggression, comprehensive ceasefire. - Neither side is negotiating. Classic impasse. The toll system monetizes the blockade — Iran has incentive to maintain, not resolve. DEFENSIVE DIVERSIFICATION RESEARCH: PG (Procter & Gamble): ~$153, PE 22.54, yield 2.7%, beta 0.34-0.40. - Pro: Extremely low beta. 65-year dividend increase streak. Predictable business. No litigation tail risk. - Con: Flat organic growth. $1B tariff headwind in FY2026. Private label competition. - Assessment: PUREST defensive play. Quantifiable, cyclical risks. JNJ (Johnson & Johnson): ~$236, PE 22.06, yield 2.14%, beta 0.35. - Pro: Revenue growth 9.1%. Hit all-time high March 2 during correction. Strong pharma pipeline. - Con: 67,115 pending talc lawsuits (largest active MDL in US). Failed 'Texas Two-Step' 3 times. Recent $50M and $1.5B adverse verdicts. - Assessment: Better fundamentals but MASSIVE litigation tail risk. UNH (UnitedHealth): ~$259.64, PE 15.80, yield 3.13%, beta 0.38. - Pro: Lowest PE, highest yield, lowest beta. - Con: Losing 1.3-1.4M members. Medicaid margin collapsed (-0.1% to -1.8%). Revenue guidance cut. - Assessment: Cheap for a reason. Company-specific headwinds are real. VERDICT: PG is the best defensive pick for our portfolio. We already have enough binary risk (NVDA/AVGO thesis, Iran/XOM). PG adds genuinely uncorrelated, predictable defensive exposure with the highest dividend yield of the three. Consider 5-8% allocation ($5-8K) when stress indicators normalize. RATE HIKE ANALYSIS: - Fed funds futures: 52% probability of hike by end of 2026. 94% probability of hold at next meeting. - 12% probability of April hike. Shift from 0% hike probability in early February. - Fed Chair Powell (March 18): Oil price impact 'may be temporary.' Vice Chair Jefferson: 'not necessarily an impetus to raise rates.' - Bank of America published analysis of conditions that would force a hike. - Key insight: The Fed is signaling patience. 52% is not 80%. The rate hike narrative is a headwind but not yet a regime change. - Trigger: If probability sustains >65% for 3+ consecutive days, reassess growth positions. VIX HISTORICAL ANALYSIS: - 31 instances of VIX climbing above 30 since 1990 (after being below for 30+ days). - Average correction: 188 days. Excluding dot-com/GFC: 74 days (~2.5 months). - Current correction started ~Feb 25 = 30 days. If average, roughly halfway. - When VIX hits 40: S&P 500 up >30% on average 1 year later, positive >90% of the time. - VIX historically mean-reverts toward ~20. Spikes tend to reverse quickly. - Caveat: Pattern breaks in prolonged bear markets (2000-2002, 2007-2009). - Our situation: catalyst-driven (Iran/oil), not structural. More likely to resolve than prolonged bear.

WEEKEND ASSESSMENT: The research confirms our defensive positioning is correct. Two key revelations: 1. AVGO BROKE $300 INTRADAY ($298.87 low). This means the $300 support is NOT solid — it was tested and briefly broken. The closing at $300.68 and after-hours at $300.12 suggests the level will be tested again Monday. The Monday trim plan should stay active: if AVGO opens below $300, trim 50% immediately. 2. BRENT AT $112.57 is only $2.43 from the third stress threshold ($115). If oil breaks $115, we'd have 3/3 stress indicators — maximum defensive posture. In that scenario, consider trimming AVGO entirely (not just 50%) and raising cash to 60%+. WEEK 1 FINAL NUMBERS: - Portfolio: $97,051 (-2.95%) - vs Nasdaq: -11%+ from highs. S&P -6.8% in March. - Alpha: ~8% outperformance through cash + energy hedge. - The 52% cash position is the single best decision we've made. PLAYBOOK PERFORMANCE: - 5/5 principles validated this week - 6/7 lessons relevant and correct - 4/5 what_works patterns confirmed - Stress indicator system triggered at exactly the right time The playbook is working. Don't change what's working — refine it. KEY INSIGHT FROM VIX ANALYSIS: Historically, VIX above 30 means the correction is roughly halfway done (if we exclude extreme outliers). Current correction is 30 days old, average is 74 days excluding outliers. This suggests 1-2 more months of volatility. Plan accordingly — don't rush to deploy cash.

MONDAY DECISION MATRIX (final): 1. AVGO opens below $300 → trim 50% (23 shares) immediately 2. Brent breaks $115 → consider trimming AVGO entirely, raise cash to 60%+ 3. VIX opens above 30 → absolutely no new positions 4. Iran positive response → watch for tech bounce, do NOT chase 5. Iran escalation → stay defensive, 52% cash 6. Rate hike probability >65% sustained → begin AVGO exit planning WEEK 2 PRIORITIES: 1. Monitor AVGO $300 support (most critical level in portfolio) 2. Track Brent vs $115 threshold (would trigger 3/3 stress) 3. Begin PG research for 5-8% allocation when stress normalizes 4. Watch April 6 Hormuz deadline — binary catalyst 5. Monitor rate hike probability — Fed says temporary but market disagrees NO NEW POSITIONS until VIX <25 AND 30Y <4.7%.